Pegylated interferon alfa 2b (PEG-IFN) and ribavirin for hepatitis C patients who were nonresponders to previous therapy

被引：0
|
作者：
Lawitz, EJ
Cantu, NS
Becker, S
Dhar, R
Li, J
Bala, NS
Gordon, S
Davis, M
Nader, P
Holtzmuller, K
Rosenfield, T
Monsour, H
机构：
来源：
GASTROENTEROLOGY | 2002年 / 122卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
80
引用
收藏
页码：A626 / A626
页数：1
相关论文
共 50 条
  • [31] Consensus interferon plus ribavirin therapy in patients who are nonresponders or relapsers to prior PEG IFN plus ribavirin
    Ghalib, Reem H.
    Levine, Cheryl D.
    Friedman, Daniel A.
    Rashdan, Sawsan
    Schwartz, Armond G.
    Weinstein, Jeffrey
    GASTROENTEROLOGY, 2007, 132 (04) : A794 - A794
  • [32] The pharmacokinetics of pegylated-40K interferon alfa-2a (PEG-IFN) in chronic hepatitis C (CHC) patients with cirrhosis
    Heathcote, EJ
    Pockros, PJ
    Fried, MW
    Bain, MA
    DePamphilis, J
    Modi, M
    GASTROENTEROLOGY, 1999, 116 (04) : A735 - A735
  • [33] Early prediction of response to Peg-IFNα-2a or Peg-IFNα-2b plus ribavirin in the single chronic hepatitis C patients by modeling the dynamics of infected cells
    Ciccorossi, P.
    Colombatto, P.
    Maina, A.
    Civitano, L.
    Oliveri, F.
    Sacco, R.
    Coco, B.
    Bonino, F.
    Brunetto, M.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S26 - S27
  • [34] Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C: A trial in prior nonresponders to interferon monotherapy or combination therapy and in combination therapy relapsers
    Jacobson, IM
    Russo, MW
    Brown, RS
    Lebovics, E
    Min, A
    Esposito, S
    Tobias, H
    Klion, F
    Rovner, D
    Brass, C
    GASTROENTEROLOGY, 2002, 122 (04) : A626 - A626
  • [35] Interferon and ribavirin in HIV-negative haemophiliacs with chronic hepatitis C who were nonresponders to a previous interferon treatment
    Franchini, M
    Tagliaferri, A
    Rossetti, G
    Capra, F
    Veneri, D
    De Maria, E
    Pattacini, C
    Aprili, G
    Gandini, G
    HAEMOPHILIA, 2002, 8 (06) : 794 - 797
  • [36] Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C: A trial in prior nonresponders to interferon monotherapy or combination therapy, and in combination therapy relapsers
    Jacobson, IM
    Russo, MW
    Brown, RS
    Lebovics, E
    Min, A
    Esposito, S
    Tobias, H
    Klion, F
    Pizov, O
    Brass, C
    GASTROENTEROLOGY, 2001, 120 (05) : A383 - A383
  • [37] Early dynamics of viremia in patients with genotype 1b chronic hepatitis C: Peg-IFNα2a shows earlier viral decline than peg-IFNα2b in combination therapy with ribavirin
    Fujino, Tatsuya
    Nakamuta, Makoto
    Aoyagi, Yoko
    Kohjima, Motoyuki
    Satoh, Takeaki
    Fukuda, Mika
    Ishibashi, Hiromi
    Yatsuhashi, Hiroshi
    Enjoji, Munechika
    MEDICAL SCIENCE MONITOR, 2011, 17 (12): : CR687 - CR691
  • [38] Pegylated interferon (PEG-IFN) α-2b+ribavirin (RB) in the treatment of post-liver transplant (LT) recurrent hepatitis C
    Martini, S
    Lavezzo, B
    Saettone, S
    Franchello, A
    Smedile, A
    Cocchis, D
    Ghisetti, V
    David, E
    Salizzoni, M
    Rizzetto, M
    JOURNAL OF HEPATOLOGY, 2005, 42 : 55 - 55
  • [39] Treatment with Peg-Interferon alfa-2b (PEG-IFN) plus ribavirin compared to interferon alfa-2b (INF alfa-2b)plus ribavirin on subjects with chronic hepatitis C infected with HCV genotype 4.
    Esmat, G
    Abouzied, AM
    Abdel-Aziz, F
    Mohamed, MK
    Abdel-Hamid, M
    El Raziky, MS
    Ismail, SA
    Zalata, KR
    Mikhail, NN
    Fix, A
    Strickland, T
    Sjogren, MH
    HEPATOLOGY, 2002, 36 (04) : 364A - 364A
  • [40] PEG-IFN alfa-2a plus ribavirin is superior compared to high dose consensus interferon (CIFN) and ribavirin in the treatment of patients with chronic hepatitis C
    Witthoeft, T.
    Fuchs, M.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S248 - S248
12345